To perform a cost analysis of simultaneous pancreas-kidney transplantation (SPKT) in a Brazilian hospital.
Introduction
The first pancreas transplant in the world was performed Simultaneous pancreas-kidney transplantation (SPKT) has a higher technical complication rate compared with other transplants, which increases the cost of the procedure. The Brazilian health system has two types of health insurance: a public health system (i.e., Unique Health System, SUS) and a supplementary system (SS); the majority of patients belong to the former. It is important to transplant teams, institutions, and the health system to assess the economic viability of SPKT.
Few data are available regarding the finances of SPKT.
Gruessner et al. until the day that the patient was discharged. The data were analyzed separately for each of the two Brazilian health systems (SUS and SS).
All costs were evaluated monthly, converted to dollars, and then corrected to the official dollar value for December 2011, according to the IPCA and the IBGE; therefore, the values are expressed in US dollars and as medians.
Statistical analysis
The relationships among the variables were assessed using an unpaired Student's t-test for continuous variables and a chi-squared analysis for categorical variables. Differences in financial data medians were assessed using the Mann-Whitney U-test. All statistical analyses were performed using StatView (version 5.0.1) (Abacus Concepts, Inc., Berkley, CA, USA).
Results
There were no significant age differences between the patients who were discharged and those who died. Men comprised a relatively higher percentage of patients, and there were no significant cost differences based on gender.
There was a significant difference in the mean total cost between the two payment sources, p=0.007 ( 6 . In our study, the only complication measured was death, and no cost difference was found when the deceased patients were compared with the patients discharged alive.
Of the eight patients who died, the causes were sepsis (n=4), cardiovascular events (n=3), and hemorrhagic shock (n=1).
It is possible that there is no cost difference between the deceased patients and those who were discharged because early deaths shortened the hospitalizations of these patients. There was also a higher cost for SPKT in patients with SS, and the difference was significant; however, the FOR margin was higher in this group. We believe that the lower gain margin in the SUS is offset by the high volume of this patient group. Cohn et al. 8 found similar data in their study, which described a higher cost of complications for patients with Medicare insurance.
Conclusions
Simultaneous pancreas-kidney transplantation (SPKT)
is an economically viable process for Brazilian health institutions.
The mortality rate does not indicate an increase in costs for the procedure. The highest cost is for medical supplies. It is necessary to assess the impact of all complications to analyze the cost of SPKT. To study the economic feasibility of the procedure, the billing was compared to the procedure cost and was analyzed by separating the data by the payment source. The FOR was positive for both groups and averaged $5620.65. However, when differentiating between the payment sources, a higher gain was found in the SUS; this difference was statistically significant (p=0.002).
Discussion
To establish the economic feasibility of SPKT, it is to measure its costs and profits. In a systematic literature search of United States, European, and Latin American publications, little data are available concerning the finances of SPKT. Troppman et al. 5 studied the complication rates associated with pancreas
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